Published in Harefuah on October 15, 1980
Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology (2007) 3.82
A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet (1998) 3.76
The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat Genet (2001) 2.71
Mitochondrial abnormalities in oculopharyngeal muscular dystrophy. Muscle Nerve (1991) 2.65
Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses. Neurology (1998) 2.39
Endothelin in cerebrospinal fluid and plasma of patients in the early stage of ischemic stroke. Stroke (1997) 1.62
Open controlled therapeutic trial of intravenous immune globulin in relapsing-remitting multiple sclerosis. Arch Neurol (1992) 1.61
High incidence of primary cerebral lymphoma in tumor-induced central neurogenic hyperventilation. Arch Neurol (1989) 1.59
Various types of hereditary inclusion body myopathies map to chromosome 9p1-q1. Ann Neurol (1997) 1.53
Quantitative anal sphincter EMG in multisystem atrophy and 100 controls. J Neurol Neurosurg Psychiatry (2001) 1.42
Autosplenectomy complicating pneumococcal meningitis in an adult. Arch Intern Med (1991) 1.41
High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis. Semin Arthritis Rheum (1998) 1.40
Optic neuritis complicating west nile virus meningitis in a young adult. Infection (2003) 1.39
Postictal blindness in adults. J Neurol Neurosurg Psychiatry (1983) 1.30
Skin wrinkling on immersion of hands: a test of sympathetic function. Arch Neurol (1979) 1.29
Hereditary inclusion body myopathy: the Middle Eastern genetic cluster. Neurology (2003) 1.20
Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia. Neurology (1998) 1.19
A simple CSF manometric test for adult hydrocephalus associated with dementia. A comparison with radioisotope encephalography. Eur Neurol (1971) 1.19
Skin biopsy for assessment of autonomic denervation in Parkinson's disease. J Neural Transm (Vienna) (2006) 1.09
Clinical presentations of mitochondrial cardiomyopathies. Pediatr Cardiol (2004) 1.08
Extracranial metastases of medulloblastoma in adults: literature review. J Neurol Neurosurg Psychiatry (1991) 1.04
Vincristine treatment triggering the expression of asymptomatic Charcot-Marie-Tooth disease. Med Pediatr Oncol (1996) 1.03
Dysferlinopathy in the Jews of the Caucasus: a frequent mutation in the dysferlin gene. Neuromuscul Disord (2007) 1.00
Clinical features of oculopharyngeal muscular dystrophy among Bukhara Jews. Neuromuscul Disord (1994) 0.99
Strokes mimicking peripheral nerve lesions. Clin Neurol Neurosurg (1995) 0.98
Neuropsychological aspects of benign childhood epilepsy with centrotemporal spikes. Seizure (2009) 0.96
Surgical extirpation of a venous angioma of the medulla oblongata simulating multiple sclerosis. Surg Neurol (1982) 0.95
Neurocognitive correlates of anxiety disorders in children: a preliminary report. J Anxiety Disord (2000) 0.95
Intravenous administration of magnesium sulfate in acute stroke: a randomized double-blind study. Clin Neuropharmacol (2001) 0.94
Chronic myopathy induced by repeated bupivacaine injections. J Neurol Sci (1985) 0.94
Muscular dystrophy due to dysferlin deficiency in Libyan Jews. Clinical and genetic features. Brain (2000) 0.92
Sexual dysfunction in relapsing-remitting multiple sclerosis: magnetic resonance imaging, clinical, and psychological correlates. J Psychiatry Neurosci (1996) 0.92
Early treatment of a single generalized tonic-clonic seizure to prevent recurrence. Arch Neurol (1996) 0.91
Subacute spongiform encephalopathy and its relation to Jakob-Creutzfeldt disease: report on six cases. J Neurol Neurosurg Psychiatry (1972) 0.91
Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin. Acta Neurol Scand (2008) 0.90
Agenesis of the corpus callosum in a mother and son. Am J Med Genet (1997) 0.89
A new approach to affective symptoms in relapsing-remitting multiple sclerosis. Compr Psychiatry (1996) 0.89
Neuroaxonal dystrophy and hemosiderin in the central nervous system. Ann Neurol (1980) 0.89
Common peroneal neuropathy due to surfing. J Child Neurol (2000) 0.89
Neurological and functional outcome in patients with supratentorial hemorrhages. A prospective study. Stroke (1995) 0.88
T cell vaccination in multiple sclerosis relapsing-remitting nonresponders patients. Clin Immunol (2004) 0.88
Congenital visual agnosia and prosopagnosia in a child: a case report. Cortex (1996) 0.88
Physical and transcriptional map of the hereditary inclusion body myopathy locus on chromosome 9p12-p13. Eur J Hum Genet (2001) 0.88
Establishment of the genomic structure and identification of thirteen single-nucleotide polymorphisms in the human RECK gene. Cytogenet Genome Res (2002) 0.87
Apomorphine in Parkinsonian tremor. Br Med J (1970) 0.87
Cerebrospinal fluid soluble interleukin-2 receptor in cerebral lupus. Br J Rheumatol (1997) 0.86
Annexin V SPECT imaging of phosphatidylserine expression in patients with dementia. Neurology (2006) 0.86
Selective acalculia with sparing of the subtraction process in a patient with left parietotemporal hemorrhage. Neurology (1994) 0.86
Hexosaminidase A deficiency manifesting as spinal muscular atrophy of late onset. Ann Neurol (1988) 0.86
Multiple sclerosis in childhood and adolescence: clinical features and management. Paediatr Drugs (2001) 0.86
Skewed X-inactivation in a manifesting carrier of X-linked myotubular myopathy and in her non-manifesting carrier mother. Hum Genet (1999) 0.85
Vocal cord paralysis as a presenting sign in the Shy-Drager syndrome. J Laryngol Otol (1988) 0.85
Effects of anticholinergic drugs on memory in Parkinson's disease. Arch Neurol (1982) 0.85
Severe anemia associated with transient neurological deficits. Stroke (1991) 0.85
Serum leptin level in women with idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry (2002) 0.84
Prevalence of glucose intolerance in patients with Bell's palsy. Isr J Med Sci (1973) 0.84
Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke (1991) 0.84
Oral phenylalanine and tyrosine tolerance tests in Parkinsonian patients. Br Med J (1969) 0.82
Muscle fibre necrosis induced by intramuscular injection of drugs. Br J Exp Pathol (1989) 0.82
Stress and epilepsy: the Gulf war experience. Seizure (1994) 0.82
Congenital myasthenia associated with facial malformations in Iraqi and Iranian Jews. A new genetic syndrome. Brain (1990) 0.82
Neonatal vocal cord paralysis-an early presentation of hereditary neuralgic amyotrophy due to a mutation in the SEPT9 gene. Eur J Paediatr Neurol (2012) 0.82
Transient global amnesia -- not always a benign process. Acta Neurol Scand (2004) 0.82
Histochemistry of human laryngeal muscles. Cell Mol Biol Incl Cyto Enzymol (1981) 0.81
Giant axonal neuropathy with predominant central nervous system manifestations. Dev Med Child Neurol (1992) 0.81
Weight gain, increased appetite, and excessive food intake induced by carbamazepine. Clin Neuropharmacol (1991) 0.81
Cerebrospinal fluid magnesium level as a prognostic factor in ischaemic stroke. J Neurol (1998) 0.81
Cerebellar involvement in Langerhans' cell histiocytosis: a progressive neuropsychiatric disease. J Child Neurol (2000) 0.80
A new point mutation affecting the fourth transmembrane domain of PMP22 results in severe de novo Charcot-Marie-Tooth disease. Hum Genet (1996) 0.80
Immunoglobulin treatment in refractory Myasthenia gravis. Muscle Nerve (2000) 0.79
Health risks among shift workers: a survey of female nurses. Health Care Women Int (1997) 0.79
In vivo 23Na NMR studies of myotonic dystrophy. Magn Reson Med (1997) 0.79
Antiepileptic treatment in patients with early postischemic stroke seizures: a retrospective study. Cerebrovasc Dis (2001) 0.79
Spinal intradural arachnoid cysts. Neurochirurgia (Stuttg) (1991) 0.79
Observations on the innervation of human extraocular muscles. J Neurol Sci (1985) 0.79
Minimal time interval in auditory temporal resolution. J Aud Res (1985) 0.79
Cerebrospinal fluid lactate dehydrogenase levels in early stroke and transient ischemic attacks. Stroke (1990) 0.79
Epidemiology and inheritance of oculopharyngeal muscular dystrophy in Israel. Neuromuscul Disord (1997) 0.79
Posterior semicircular canal type benign paroxysmal positioning vertigo with ageotropic paroxysmal positioning nystagmus. Audiol Neurootol (2001) 0.79
Intracranial esthesioneuroblastoma associated with unilateral visual loss. Case report. J Neurosurg (1980) 0.78
Multifocal neuropathy and vocal cord paralysis in relapsing fever. Eur Neurol (1982) 0.78
Brain atrophy, hydrocephalus and dementia in adults. Isr J Med Sci (1970) 0.78
L-dopa and favism. Blood (1971) 0.78
Myotoxicity and neurotoxicity during clozapine treatment. Clin Neuropharmacol (2001) 0.78
Changes in end-plate cholinesterase and axons during muscle degeneration and regeneration. J Anat (1985) 0.77
Intranuclear inclusions in oculopharyngeal muscular dystrophy among Bukhara Jews. Neurology (1996) 0.77
Homozygosity by descent for a rare mutation in the myophosphorylase gene is associated with variable phenotypes in a Druze family with McArdle disease. J Med Genet (1997) 0.77
Familial dyslexia associated with cavum vergae. Clin Neurol Neurosurg (1997) 0.77
Vascular insufficiency quantitatively aggravates diabetic neuropathy. Arch Neurol (1991) 0.77
Transient loss of speech after removal of posterior fossa tumors--one aspect of a larger neuropsychological entity: the cerebellar cognitive affective syndrome. Pediatr Hematol Oncol (2001) 0.77
Botulinum toxin for the treatment of oro-facial-lingual-masticatory tardive dyskinesia. Mov Disord (2000) 0.77
Benign intracranial hypertension: correlation of cerebral blood flow with disease severity. Clin Neurol Neurosurg (2001) 0.77
Fine-structure mapping of the hereditary inclusion body myopathy locus. Genomics (1999) 0.77
Decreased erythrocyte glutathione peroxidase activity in multiple sclerosis. Acta Neurol Scand (1979) 0.76
Hereditary motor-sensory neuropathy (Charcot-Marie-Tooth disease) with nerve deafness: a new variant. J Pediatr (1993) 0.76
Glutathione peroxidase activity in various types of blood cells in multiple sclerosis. Acta Neurol Scand (1981) 0.76
Intravenous gammaglobulin treatment in multiple sclerosis and experimental autoimmune encephalomyelitis: delineation of usage and mode of action. J Neurol Neurosurg Psychiatry (1994) 0.76
Intravenous immune globulin in multiple sclerosis: clinical and neuroradiological results and implications for possible mechanisms of action. Clin Exp Immunol (1996) 0.75